Goldman Sachs Reinstates 4D Molecular Therapeutics (FDMT) at Buy, 'Platform value to inflect via 2024 catalysts'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. NVDA
6. WYFI
7. STUB
8. EAT
9. ARX
10. BTGO

Go back to Goldman Sachs Reinstates 4D Molecular Therapeutics (FDMT) at Buy, 'Platform value to inflect via 2024 catalysts'
(NASDAQ: FDMT) Delayed: 11.65 -0.22 (1.85%)
Previous Close $11.87    52 Week High $ 
Open $11.93    52 Week Low $ 
Day High $12.05    P/E N/A 
Day Low $11.34    EPS $ 
Volume 707,434